Emeline Gernez

Dr. Emeline Gernez


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Toxics
Verified
Journal Article
Open access
PDF file
EGEmeline Gernez
Emeline Gernez
GLGraham Lee
Graham Lee
JNJean-Paul Niguet
Jean-Paul Niguet
FZFarid Zerimech
Farid Zerimech
ABAnas Bennis
Anas Bennis
GGGuillaume Grzych
Guillaume Grzych
The recreational use of nitrous oxide (N2O), also called laughing gas, has increased significantly in recent years. In 2022, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) recognized it as one of the most prevalent psychoactive substances used in Europe. Chronic nitrous oxide (N2O) exposure can lead to various clinical manifestations. The most frequent symptoms are neurological (sensitive or motor disorders), but there are also other manifestations like psychiatric manifestations or cardiovascular disorders (thrombosis events). N2O also affects various neurotransmitter systems, leading to its anesthetic, analgesic, anxiolytic and antidepressant properties. N2O is very challenging to measure in biological matrices. Thus, in cases of N2O intoxication, indirect biomarkers such as vitamin B12, plasma homocysteine and plasma MMA should be explored for diagnosis and assessment. Others markers, like oxidative stress markers, could be promising but need to be further investigated.

23 December 2022 in Toxics
Verified
Journal Article
Open access
PDF file
EGEmeline Gernez
Emeline Gernez
SDSylvie Deheul
Sylvie Deheul
CTCéline Tard
Céline Tard
MJMarie Joncquel
Marie Joncquel
CDClaire Douillard
Claire Douillard
GGGuillaume Grzych
Guillaume Grzych
In the last few years, there has been an increase in the recreational use of nitrous oxide (N2O), which can lead to neurological symptoms such as sensory or motor disorders. The literature links these symptoms to a functional inactivation of vitamin B12 by oxidation of its cobalt ion, which prevents the vitamin B12 from acting as a cofactor for methionine synthase. Thus, demyelination related to methionine deficiency could be responsible for the neurological disorders associated with N2O consumption, including the combined sclerosis of the spinal cord. We aimed to study the correlation between the plasma methionine levels and clinical severity observed in N2O users. We retrospectively collected clinical and biological data from 93 patients who chronically consumed N2O. The patients were divided into four groups based of the severity of their clinical symptoms (based on their Peripheral Neuropathy Disability (PND) score). The plasma amino acids measurement, including methionine, were performed systematically by liquid chromatography coupled with mass spectrometry. Plasma methionine is significantly correlated with the clinical severity (Spearman coefficient: −0.42; p-value < 10−5), however, the average methionine level in the four groups is within the physiological values (N: 16–23 µmol/L). There is a significant inverse correlation between plasma methionine and homocysteine (Spearman coefficient: −0.57; p-value < 10−9), which confirms the action of nitrous oxide on the methionine synthase. A decrease in plasma methionine cannot be imputed as the only mechanism involved in the pathophysiology of the neurological disorders in nitrous oxide consumption. In addition, there are few therapeutic indications for the use of methionine. Thus, we should be careful concerning the potential use of methionine in nitrous oxide consumption. As a consequence, other pathophysiological mechanisms probably need to be identified in order to find potential therapeutic targets.

14 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
GGGuillaume Grzych
Guillaume Grzych
MSMarie Scuccimarra
Marie Scuccimarra
LPLaura Plasse
Laura Plasse
EGEmeline Gernez
Emeline Gernez
FCFrancois Cassim
Francois Cassim
CTCéline Tard
Céline Tard
Background: The incidence of neurological complications associated with nitrous oxide (N2O) abuse, including N2O-induced myelopathy and neuropathy, has risen in the past decade. N2O-induced neuropathy often presents as a subacute axonal pathology; however, demyelinating patterns mimicking Guillain–Barré syndrome have also been observed. This study explores the metabolic pathophysiology of N2O-induced neuropathy, focusing on the alteration in metabolism to provide a deeper understanding of the biochemical pathways influencing the diverse electrophysiological patterns observed. Methods: We conducted a combined metabolic and electrophysiological exploration of 35 patients who underwent electromyographic exams at our referral center over a three-year period for sensorimotor symptoms linked to recreational N2O use. We collected demographic, clinical, radiological, electrophysiological, and biological data. Patients were categorized into axonal or demyelinating groups based on their electrophysiological patterns, and metabolic parameters were compared. Results: Our cohort predominantly exhibited a length-dependent sensorimotor axonal symmetrical neuropathy affecting the lower limbs. Among the patients, 40% met the demyelinating criteria, with four patients exhibiting conduction blocks. The demyelinating group had a significantly higher peripheral neuropathy disability (PND) score at diagnosis. Elevated homocysteine and methylmalonic acid (MMA) levels were noted in all patients, but these were lower in the demyelinating group. Conclusions: This study highlights the diverse electrophysiological manifestations of N2O-induced neuropathy and underscores the potential role of metabolic parameters as biomarkers to understand its pathophysiology. Lower hyperhomocysteinemia and MMA levels were observed in demyelinating patterns. In this study, we did not observe further improvement, but it is well-known that demyelinating features have a better prognosis related to the further remyelination. These findings contribute to a better understanding of N2O-related neuropathic damage and could guide future therapeutic interventions based on biochemical–neurophysiological stratifications.

31 May 2025 in Toxics
Verified
Journal Article
Open access
PDF file
GGGuillaume Grzych
Guillaume Grzych
RDRémy Diesnis
Rémy Diesnis
TDThierry Dupré
Thierry Dupré
JNJean Paul Niguet
Jean Paul Niguet
EGEmeline Gernez
Emeline Gernez
ACAnthony CHAUVIN
Anthony CHAUVIN
Nitrous oxide (N2O) was originally used for medical and industrial purposes, but its recreational use has dramatically increased, raising a major global public health concern. Chronic inhalation is associated with neurological, metabolic, and psychiatric complications, as well as addiction. To address these challenges, the PROTOSIDE network was developed to provide a multidisciplinary approach to management and prevention. This initiative relies on competence centers integrating specialists in emergency medicine, neurology, clinical biochemistry, and addiction medicine. PROTOSIDE aims to standardize diagnostic protocols, optimize patient care pathways, and strengthen addictovigilance. A strong emphasis is placed on prevention, including awareness campaigns and collaboration with healthcare professionals and educators. By facilitating access to advanced biochemical analyses (homocysteine, methylmalonic acid) and promoting international guidelines, PROTOSIDE represents an innovative model for a global response to N2O misuse. This integrated approach enhances clinical management, reduces complications, and harmonizes public health strategies.

1 April 2025 in Annales de biologie clinique
Verified
Journal Article
Closed access
PDF file
EGEmeline Gernez
Emeline Gernez
YNYasmine Nezzar
Yasmine Nezzar
MOMouhamed Ouni
Mouhamed Ouni
CLCharles R. Lefèvre
Charles R. Lefèvre
JSJessica Sanda
Jessica Sanda
VGVincent Guillet
Vincent Guillet
Clinical biology plays a crucial role in healthcare. However, this specialty is facing a loss in attractiveness in medical studies. What is driving this decline in interest? Based on insights from the "Livre Blanc de la Formation en Biologie Médicale", written and validated by two unions representing laboratory medicine residents in France, and the insight of young clinical biologists, this article delves into young biologists' perspectives on their profession, through the eyes of the "New Generation in Clinical Biology" task force of the French Clinical Biology Society (SFBC). We explore key challenges our field will have to overcome for the new generation. At the same time, we shed light on their aspirations: modernizing missions, promoting research, and expanding career opportunities. Finally, we propose concrete solutions to revitalize the field and ensure a stronger integration of young professionals into the healthcare system.